407 related articles for article (PubMed ID: 32348995)
21. The podocin V260E mutation predicts steroid resistant nephrotic syndrome in black South African children with focal segmental glomerulosclerosis.
Govender MA; Fabian J; Gottlich E; Levy C; Moonsamy G; Maher H; Winkler CA; Ramsay M
Commun Biol; 2019; 2():416. PubMed ID: 31754646
[TBL] [Abstract][Full Text] [Related]
22. Novel variants in CRB2 targeting the malfunction of slit diaphragm related to focal segmental glomerulosclerosis.
Yang Q; Tang D; Gan C; Bai M; Song X; Jiang W; Li Q; Chen Y; Zhang A; Wang M
Pediatr Nephrol; 2024 Jan; 39(1):149-165. PubMed ID: 37452832
[TBL] [Abstract][Full Text] [Related]
23. Mutations in KIRREL1, a slit diaphragm component, cause steroid-resistant nephrotic syndrome.
Solanki AK; Widmeier E; Arif E; Sharma S; Daga A; Srivastava P; Kwon SH; Hugo H; Nakayama M; Mann N; Majmundar AJ; Tan W; Gee HY; Sadowski CE; Rinat C; Becker-Cohen R; Bergmann C; Rosen S; Somers M; Shril S; Huber TB; Mane S; Hildebrandt F; Nihalani D
Kidney Int; 2019 Oct; 96(4):883-889. PubMed ID: 31472902
[TBL] [Abstract][Full Text] [Related]
24. Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how?
Preston R; Stuart HM; Lennon R
Pediatr Nephrol; 2019 Feb; 34(2):195-210. PubMed ID: 29181713
[TBL] [Abstract][Full Text] [Related]
25. Pathophysiology of focal segmental glomerulosclerosis.
Reidy K; Kaskel FJ
Pediatr Nephrol; 2007 Mar; 22(3):350-4. PubMed ID: 17216262
[TBL] [Abstract][Full Text] [Related]
26. APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries.
Gribouval O; Boyer O; Knebelmann B; Karras A; Dantal J; Fourrage C; Alibeu O; Hogan J; Dossier C; Tête MJ; Antignac C; Servais A
Nephrol Dial Transplant; 2019 Nov; 34(11):1885-1893. PubMed ID: 29992269
[TBL] [Abstract][Full Text] [Related]
27. Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.
Doublier S; Zennaro C; Musante L; Spatola T; Candiano G; Bruschi M; Besso L; Cedrino M; Carraro M; Ghiggeri GM; Camussi G; Lupia E
PLoS One; 2017; 12(11):e0188045. PubMed ID: 29155846
[TBL] [Abstract][Full Text] [Related]
28. Low prevalence of NPHS2 mutations in African American children with steroid-resistant nephrotic syndrome.
Chernin G; Heeringa SF; Gbadegesin R; Liu J; Hinkes BG; Vlangos CN; Vega-Warner V; Hildebrandt F
Pediatr Nephrol; 2008 Sep; 23(9):1455-60. PubMed ID: 18543005
[TBL] [Abstract][Full Text] [Related]
29. Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severity.
Bullich G; Trujillano D; Santín S; Ossowski S; Mendizábal S; Fraga G; Madrid Á; Ariceta G; Ballarín J; Torra R; Estivill X; Ars E
Eur J Hum Genet; 2015 Sep; 23(9):1192-9. PubMed ID: 25407002
[TBL] [Abstract][Full Text] [Related]
30. Association of HLA-DR/DQ alleles and haplotypes with nephrotic syndrome.
Ramanathan AS; Senguttuvan P; Chinniah R; Vijayan M; Thirunavukkarasu M; Raju K; Mani D; Ravi PM; Rajendran P; Krishnan JI; Karuppiah B
Nephrology (Carlton); 2016 Sep; 21(9):745-52. PubMed ID: 26566811
[TBL] [Abstract][Full Text] [Related]
31. The genetic basis of FSGS and steroid-resistant nephrosis.
Pollak MR
Semin Nephrol; 2003 Mar; 23(2):141-6. PubMed ID: 12704574
[TBL] [Abstract][Full Text] [Related]
32. Salvianolic acid A attenuates steroid resistant nephrotic syndrome through suPAR/uPAR-αvβ3 signaling Inhibition.
Li X; Qi D; Wang MY; Ji K; Xie QL; Wang Y; Du SH; Fan HY
J Ethnopharmacol; 2021 Oct; 279():114351. PubMed ID: 34157324
[TBL] [Abstract][Full Text] [Related]
33. A prospective study of collapsing focal segmental glomerulosclerosis.
Raja R; Nada R; Yadav AK; Kumar A; Goyal A; Kumar V; Rathi M; Kohli HS; Gupta KL; Sakhuja V; Jha V
Ren Fail; 2016 Jul; 38(6):894-8. PubMed ID: 27266801
[TBL] [Abstract][Full Text] [Related]
34. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
[TBL] [Abstract][Full Text] [Related]
35. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.
Ruf RG; Lichtenberger A; Karle SM; Haas JP; Anacleto FE; Schultheiss M; Zalewski I; Imm A; Ruf EM; Mucha B; Bagga A; Neuhaus T; Fuchshuber A; Bakkaloglu A; Hildebrandt F;
J Am Soc Nephrol; 2004 Mar; 15(3):722-32. PubMed ID: 14978175
[TBL] [Abstract][Full Text] [Related]
36. HISTOPATHOLOGICAL PATTERNS IN PAEDIATRIC IDIOPATHIC STEROID RESISTANT NEPHROTIC SYNDROME.
Shah SS; Akhtar N; Sunbleen F; ur Rehman MF; Ahmed T
J Ayub Med Coll Abbottabad; 2015; 27(3):633-6. PubMed ID: 26721026
[TBL] [Abstract][Full Text] [Related]
37. Altered expression of Crb2 in podocytes expands a variation of CRB2 mutations in steroid-resistant nephrotic syndrome.
Udagawa T; Jo T; Yanagihara T; Shimizu A; Mitsui J; Tsuji S; Morishita S; Onai R; Miura K; Kanda S; Kajiho Y; Tsurumi H; Oka A; Hattori M; Harita Y
Pediatr Nephrol; 2017 May; 32(5):801-809. PubMed ID: 27942854
[TBL] [Abstract][Full Text] [Related]
38. Association of steroid and cyclosporin resistance in focal segmental glomerulosclerosis.
Shatat IF; Schoeneman M; Flynn JT; Woroniecki RP
Pediatr Nephrol; 2007 Jun; 22(6):834-9. PubMed ID: 17294224
[TBL] [Abstract][Full Text] [Related]
39. Focal segmental glomerulosclerosis and medullary nephrocalcinosis in children with ADCK4 mutations.
Park E; Kang HG; Choi YH; Lee KB; Moon KC; Jeong HJ; Nagata M; Cheong HI
Pediatr Nephrol; 2017 Sep; 32(9):1547-1554. PubMed ID: 28405841
[TBL] [Abstract][Full Text] [Related]
40. NPHS2 variation in Chinese southern infants with late steroid-resistant nephrotic syndrome.
Dai Y; Yang H; Gao P; Liu WD
Ren Fail; 2014 Oct; 36(9):1395-8. PubMed ID: 25112471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
